Vertex teams up with Affinia in gene therapies [Seeking Alpha]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Seeking Alpha
Healthcare|On the MoveVertex teams up with Affinia in gene therapiesApr. 27, 2020 9:07 AM ETVertex Pharmaceuticals... (VRTX)Douglas W. HouseVertex Pharmaceuticals (NASDAQ:collaborateAffinia TherapeuticsThe partnership will leverage Affinia's proprietary AAVSmartLibrary and associated technology with Vertex's scientific, clinical and regulatory know-how to develop gene therapies for Duchenne muscular dystrophy, myotonic dystrophy type 1 and cystic fibrosis.Under the terms of the deal, Affinia will be eligible to receive over $1.6B in payments and milestones, including $80M in upfront and research milestone fees, and tiered royalties on net sales.Affinia will be responsible for capsid discovery while Vertex will be responsible for the design, development, manufacture and commercialization of the gene therapies.Shares up2%See all stocks on the move »Now read:Regeneron and Sanofi's Kevzara shows no clinical benefit in COVID-19 study »
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Sanofi completes acquisition of VicebioGlobeNewswire
- Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) [Yahoo! Finance]Yahoo! Finance
- Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation [Yahoo! Finance]Yahoo! Finance
- AI won't cure cancer, says Sanofi CEO [CNBC]CNBC
SNY
Sec Filings
- 12/3/25 - Form 6-K
- 11/18/25 - Form 6-K
- 11/14/25 - Form SCHEDULE
- SNY's page on the SEC website